EAU 2014 - Bladder Cancer

Viewing 1-13 of 13 articles

EAU 2014 - Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects outcome of patients with muscle-invasive tumors - Session Highlights

EAU 2014 - Occult lymph node metastases in patients with muscle invasive bladder cancer: Incidence after neoadjuvant chemotherapy and cystectomy versus cystectomy alone - Session Highlights

EAU 2014 - A randomized, double blind, placebo controlled phase II trial to evaluate the safety and efficacy of recMAGE-A3 + AS15 antigen specific cancer immunotherapy in patients with MAGE-A3 positive muscle invasive bladder cancer after cystectomy...

EAU 2014 - State-of-the-art lecture: How to avoid cystectomy being too late in non-muscle-invasive bladder cancer - Session Highlights

EAU 2014 - State-of-the-art lecture: Personalized urinary diagnostics - Session Highlights

EAU 2014 - Adjuvant treatment of non-muscle-invasive bladder cancer: When and how? - Session Highlights

EAU 2014 - Is estimated GFR a reliable measurement after cystectomy and ileal loop diversion? - Session Highlights

EAU 2014 - Pre-clinical and clinical translation of a tissue engineered neo−urinary conduit using adipose derived smooth muscle cells for urinary reconstruction - Session Highlights

EAU 2014 - The curative potential of lymphadenectomy after response to chemotherapy in patients with urothelial carcinoma presenting with regional or distant nodal metastases: Analysis of a series from a tertiary cancer centre - Session Highlights

EAU 2014 - Prognostic model for predicting survival in patients with disease recurrence following radical cystectomy - Session Highlights

EAU 2014 - Debate: Surgical treatment of muscle invasive bladder cancer: Cost comparison analysis - Session Highlights

EAU 2014 - Comparison of white-light, photodynamic diagnosis and narrow-band imaging for the detection of non-muscle invasive bladder cancer: Results from a randomized multicenter diagnostic phase-III study - Session Highlights

EAU 2014 - Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma - Session Highlights